Biomarker predictors and LRT strategies for HCC recurrence post-liver transplantation: A comment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biomarker predictors and LRT strategies for HCC recurrence post-liver transplantation: A comment

Published:2024-06 Issue: Volume: Page:
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

He Tao^ORCID,Sun Ke,Zou Jieyu^ORCID

Publisher

Elsevier BV

Reference8 articles.

1. AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation;Norman;J Hepatol,2023

2. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma;Singal;Hepatology,2023

3. National trends and waitlist outcomes of locoregional therapy among liver transplant candidates with hepatocellular carcinoma in the United States;Kwong;Clin Gastroenterol Hepatol,2022

4. Hepatocellular carcinoma;Vogel;Lancet,2022

5. Impact of pretransplant bridging locoregional therapy for patients with hepatocellular carcinoma within milan criteria undergoing liver transplantation: analysis of 3601 patients from the us multicenter hcc transplant consortium;Agopian;Ann Surg,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP